Literature DB >> 23250957

Overcoming resistance to MAPK pathway inhibitors.

Michael A Davies, Scott Kopetz.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 23250957     DOI: 10.1093/jnci/djs507

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.

Authors:  Shangze Li; Ka-Wing Fong; Galina Gritsina; Ali Zhang; Jonathan C Zhao; Jung Kim; Adam Sharp; Wei Yuan; Caterina Aversa; Ximing J Yang; Peter S Nelson; Felix Y Feng; Arul M Chinnaiyan; Johann S de Bono; Colm Morrissey; Matthew B Rettig; Jindan Yu
Journal:  Cancer Res       Date:  2019-04-05       Impact factor: 12.701

2.  Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells.

Authors:  Eun-Hye Hur; Bon-Kwan Goo; Juhyun Moon; Yunsuk Choi; Jung Jin Hwang; Choung-Soo Kim; Kyun Seop Bae; Jene Choi; Suk Young Cho; Sang-Hwa Yang; Jeongbeob Seo; Gilnam Lee; Je-Hwan Lee
Journal:  Oncotarget       Date:  2017-06-20

Review 3.  Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.

Authors:  Belen Hernandez; Hibret A Adissu; Bih-Rong Wei; Helen T Michael; Glenn Merlino; R Mark Simpson
Journal:  Int J Mol Sci       Date:  2018-01-30       Impact factor: 5.923

4.  MAPK Pathway under Chronic Copper Excess in Green Macroalgae (Chlorophyta): Involvement in the Regulation of Detoxification Mechanisms.

Authors:  Fernanda Rodríguez-Rojas; Paula S M Celis-Plá; Lorena Méndez; Fabiola Moenne; Pamela T Muñoz; M Gabriela Lobos; Patricia Díaz; José Luis Sánchez-Lizaso; Murray T Brown; Alejandra Moenne; Claudio A Sáez
Journal:  Int J Mol Sci       Date:  2019-09-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.